Findings

What do systematic reviews say?

2,289 questions · 2,331 findings · 195 reviews · Pregnancy and Childbirth

Sort:Best matchNewest Highest certainty Download CSV

No studies found 480 · 20.6%GRADE not reported 288 · 12.4%Very low 467 · 20%Low 630 · 27%Moderate 338 · 14.5%High 128 · 5.5%

Summary of findings table ‐ Moxibustion plus usual care vs sham moxibustion plus usual care

Adverse events · breech presentation

1 finding from 1 review

Cephalic version by moxibustion for breech presentation 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 272 participants
GRADE not reported

Summary of findings table ‐ Moxibustion plus usual care vs usual care

Need for ECV · breech presentation

Summary of findings table ‐ Moxibustion plus usual care showed no clear difference in need for ECV compared with usual care (low certainty).

1 finding from 1 review

Cephalic version by moxibustion for breech presentation 2023 · Cochrane Headline outcomes only
RR 0.62 [0.32, 1.21]
4 studies · 692 participants
Low

Summary of findings table ‐ Moxibustion plus usual care vs usual care

Caesarean section · breech presentation

Summary of findings table ‐ Moxibustion plus usual care showed no clear difference in caesarean section compared with usual care (moderate certainty).

1 finding from 1 review

Cephalic version by moxibustion for breech presentation 2023 · Cochrane Headline outcomes only
RR 0.94 [0.83, 1.05]
6 studies · 1030 participants
Moderate

Summary of findings table ‐ Moxibustion plus usual care vs usual care

Use of oxytocin · breech presentation

Summary of findings table ‐ Moxibustion plus usual care probably leads to lower use of oxytocin compared with usual care (moderate certainty).

1 finding from 1 review

Cephalic version by moxibustion for breech presentation 2023 · Cochrane Headline outcomes only
RR 0.28 [0.13, 0.6]
1 study · 161 participants
Moderate

Summary of findings table ‐ Moxibustion plus usual care vs usual care

Low arterial cord blood pH (< 7.10) · breech presentation

Summary of findings table ‐ Moxibustion plus usual care showed no clear difference in cord blood pH less than 7.1 compared with usual care (low certainty).

1 finding from 1 review

Cephalic version by moxibustion for breech presentation 2023 · Cochrane Headline outcomes only
RR 3 [0.32, 28.38]
1 study · 212 participants
Low

Summary of findings table ‐ Moxibustion plus usual care vs usual care

Adverse events · breech presentation

It is very uncertain whether summary of findings table ‐ Moxibustion plus usual care changes adverse events compared with usual care (very low certainty).

1 finding from 1 review

Cephalic version by moxibustion for breech presentation 2023 · Cochrane Headline outcomes only
RR 48.33 [3.01, 774.86]
1 study · 122 participants
Very low

Summary of findings table ‐ Moxibustion plus usual care vs sham moxibustion plus usual care

Need for ECV ‐ not reported · breech presentation

The review found no eligible studies for this question.

1 finding from 1 review

Cephalic version by moxibustion for breech presentation 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Gestational diabetes mellitus · pregnant women (women with pre‐existing type 1 or type 2 diabetes are NOT included)

It is very uncertain whether the intervention changes gestational diabetes mellitus (very low certainty).

1 finding from 1 review

Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes 2023 · Cochrane Headline outcomes only
RR 0.53 [0.31, 0.9]
6 studies · 1140 participants
Very low

Intervention not reported

Composite of serious neonatal outcomes · infants of pregnant women

1 finding from 1 review

Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes 2023 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Intervention not reported

Neonatal hypoglycaemia · infants of pregnant women

It is very uncertain whether the intervention changes neonatal hypoglycaemia (very low certainty).

1 finding from 1 review

Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes 2023 · Cochrane Headline outcomes only
RR 3.07 [0.9, 10.52]
4 studies · 671 participants
Very low

Intervention not reported

Adiposity · infants of pregnant women

1 finding from 1 review

Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes 2023 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Intervention not reported

Diabetes · infants of pregnant women

1 finding from 1 review

Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes 2023 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Intervention not reported

Neurosensory disability · infants of pregnant women

1 finding from 1 review

Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes 2023 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Intervention not reported

Caesarean section · pregnant women (women with pre‐existing type 1 or type 2 diabetes are NOT included)

The intervention showed no clear difference in caesarean section (low certainty).

1 finding from 1 review

Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes 2023 · Cochrane Headline outcomes only
RR 0.91 [0.77, 1.07]
4 studies · 829 participants
Low

Intervention not reported

Perineal trauma · pregnant women (women with pre‐existing type 1 or type 2 diabetes are NOT included)

It is very uncertain whether the intervention changes perineal trauma (very low certainty).

1 finding from 1 review

Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes 2023 · Cochrane Headline outcomes only
RR 4 [0.45, 35.25]
1 study · 234 participants
Very low

Intervention not reported

Development of subsequent type 2 diabetes mellitus · pregnant women (women with pre‐existing type 1 or type 2 diabetes are NOT included)

1 finding from 1 review

Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes 2023 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Intervention not reported

Large‐for‐gestational age · infants of pregnant women

The intervention showed no clear difference in large‐for‐gestational age (low certainty).

1 finding from 1 review

Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes 2023 · Cochrane Headline outcomes only
RR 1.4 [0.65, 3.02]
1 study · 234 participants
Low

Intervention not reported

Perinatal mortality (stillbirth and neonatal mortality) · infants of pregnant women

1 finding from 1 review

Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes 2023 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Sildenafil vs Placebo or no active treatment

All‐cause mortality · pregnant women with fetal growth restriction

Sildenafil citrate showed no clear difference in all‐cause mortality compared with placebo or no therapy (moderate certainty).

1 finding from 1 review

Interventions affecting the nitric oxide pathway versus placebo or no therapy for fetal growth restriction in pregnancy 2023 · Cochrane Headline outcomes only
RR 1.01 [0.8, 1.27]
5 studies · 516 participants
Moderate

Sildenafil vs IV nitroglycerin

All‐cause mortality · pregnant women with fetal growth restriction

1 finding from 1 review

Interventions affecting the nitric oxide pathway versus placebo or no therapy for fetal growth restriction in pregnancy 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 23 participants
Low